Skip to content

A DNAzyme-activated engineered crRNA enables CRISPR-Cas12a biosensing of ALP and S. aureus.

Oct 2026 · Biosensors & bioelectronics · Vol 316, pp. 119360 · 0 citations · 26 references
Medicine

TL;DR

A CRISPR-Cas12a biosensor centered on a DNAzyme-activated engineered crRNA, enabling Mn2+-responsive control over its trans-cleavage activity for nucleic-acid-amplification-free detection and establishing a powerful platform for biosensing.

Abstract

CRISPR-Cas12a biosensing is hindered by insufficient sensitivity that necessitates pre-amplification, as well as the limited ability to directly detect non-nucleic-acid targets. Herein, we developed a CRISPR-Cas12a biosensor centered on a DNAzyme-activated engineered crRNA (e-crRNA), enabling Mn2+-responsive control over its trans-cleavage activity for nucleic-acid-amplification-free detection. Upon Mn2+-dependent activation, the DNAzyme cleaved the e-crRNA to liberate a full-sized crRNA1 and a split crRNA2. The combined crRNA1/crRNA2 system enhanced Cas12a trans-cleavage activity, compensating for the activity loss associated with crRNA engineering. Rational design of the split site further improved the signal-to-noise ratio. Moreover, by gating the system activation on Mn2+, the non-specific activation effects caused by spurious DNA hybridization were mitigated. When coupled with a Mn2+-responsive signal conversion strategy, this platform achieved sensitive detection of alkaline phosphatase with the LOD of 0.008 U/L and Staphylococcus aureus with the LOD of 29.76 CFU/mL. This study showcased the innovative use of Mn2+-dependent DNAzyme to efficiently activate CRISPR-Cas12a system, establishing a powerful platform for biosensing.

View source

Similar papers

Nov 2026

Cas12a Autocatalytic Amplification Coupled with a DNA-Regulated COF Nanozyme Activation for the Colorimetric Detection of Staphylococcus aureus

Staphylococcus aureus (S. aureus) is a major foodborne and clinical pathogen, and its rapid and accurate detection are essential for food safety monitoring and clinical diagnostics. Here, we developed a colorimetric platform for quantifying S. aureus that integrates circular DNA (Cir-DNA)-mediated Cas12a autocatalyti...

Yu Liu, Tian-Tian Chen, Ao-Feng Yang et al. · 0 citations
Nov 2026

CRISPR-AsCas12a with crRNA-Free Collateral Cleavage Activity for Electrochemical Diagnosis of HER2-Positive Breast Cancer.

The CRISPR-Cas12a system has revolutionized molecular diagnostics; however, the strict requirement of crRNAs and target DNA for collateral cleavage activation restricts its flexibility in non-nucleic acid diagnostics. Herein, we demonstrate that AsCas12a exhibits an RNA-free collateral cleavage activity with the presen...

Shuai Wu, Jia-Lin Xu, Yan-Ting Sun et al. · 0 citations
Open access Sep 2026

Split Activator Assembly via Aptamer Binding Enables CRISPR-Cas12a Activation with Non-Nucleic Acid Targets

The programmability of CRISPR-Cas12a has enabled transformative advances in nucleic acid detection; however, extending its activation to non-nucleic-acid targets remains highly desirable. Here, we report a universal split-activator strategy that enables programmable Cas12a activation in response to a small molecule and...

R. J. Tharu, Yusha Imtiaz, Shubhajit Singha et al. · 0 citations
#gene editing Open access Oct 2026

CRISPR/Cas12a-Based Aptasensor for Cas9 Protein Detection in Spiked Food Matrices

Residual gene editors are a concern associated with the widespread application of CRISPR/Cas9 technology. Here, we developed a CRISPR/Cas12a-based fluorescent aptasensor for the qualitative and quantitative detection of Cas9 protein. Secondary structure prediction and molecular docking were combined to identify potenti...

Zi-Zhao Wang, Jing Wang, Ling Li et al. · 0 citations
Oct 2026

A programmable aptamer-triggered B-PER/CRISPR cascade amplification platform for ultrasensitive detection of Staphylococcus aureus.

Rapid and sensitive detection of Staphylococcus aureus (S. aureus) is critical for food safety and public health. Herein, this work developed an ABC (aptamer-B-PER-CRISPR) cascade detection platform, where B-PER stands for bidirectional primer exchange reaction, that integrates aptamer-mediated target recognition, B-PE...

Jia-Lin Jiang, Yuan Peng, Wen-Jie Ma et al. · 0 citations
Oct 2026

Single-Atom Nanozyme Integrated Double-Clasp Transition Probe-Driven CRISPR/Cas12a Cascade for Preamplification-Free Detection of Non-Nucleic Acid Targets.

CRISPR/Cas12a diagnostics have greatly advanced nucleic acid testing, yet their extension to non-nucleic acid targets remains constrained by the intricate preamplification process and by inefficient signal transduction. Herein, we present a non-nucleic acid detection platform that integrates a CRISPR/Cas12a positive-fe...

Jian-Le Wang, Qiu-Yun Tian, Yu-Ling Li et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.